Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emily Botto"'
Publikováno v:
Communications Medicine, Vol 4, Iss 1, Pp 1-7 (2024)
Abstract Background Characterizing perceptions of clinical trials among the socioeconomically disadvantaged is necessary for understanding how social determinants of health such as socioeconomic disparities in education and income can affect people
Externí odkaz:
https://doaj.org/article/dd93562988584b38a2369fe4a74040ca
Publikováno v:
Therapeutic Innovation & Regulatory Science. 57:262-270
Utilizing a participation burden algorithm developed in a previous study, Tufts CSDD, in collaboration with ZS, led a workshop among 8 pharmaceutical companies to validate the methodology of benchmarking the participation burden of a set of retrospec
Autor:
Kenneth Getz, Maria Florez, Emily Botto, Kim Ribeiro, Gretchen Goller, LaShell Robinson, Omer Abdullah
Publikováno v:
Therapeutic Innovation & Regulatory Science. 56:777-784
There is little to no empirical data on the race and ethnicity of the global community of professionals conducting clinical trials funded by pharmaceutical and biotechnology companies and little empirical evidence on the relationship between the race
Publikováno v:
Therapeutic innovationregulatory science. 56(5)
Following up on a study from 2019, Tufts CSDD collected and analyzed data on demographic disparities and representation in pivotal trials supporting the marketing authorization of novel drugs and biologics approved in Europe between 2007 and 2019.Dat
Publikováno v:
Frontiers in Rehabilitation Sciences, Vol 5 (2024)
BackgroundChildren with neurodevelopmental disabilities (NDDs, e.g., cerebral palsy) and their caregivers face lifelong and impactful challenges, particularly during life-transition periods such as adolescence. One's resilience emerges as an essentia
Externí odkaz:
https://doaj.org/article/0370fb90585d4d82b3b52ea01bad8370